Biopharma money raised to-date and by month in 2026, including public, private and other financings.

Clinical updates for biopharma and med tech, including data readouts and publications: Akeso, Biogen, Bioxcel, ITM, Medicus, Parabilis, Response, Stoke.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Affinia, Bayer, Glenmark, Nxer.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cortechs.ai, Greenland, GSK, Karl Storz, Klotho, Rapt, Siemens, Shanghai Jeyou, Takeda, Veraxa, Voyager, Womed.

Clinical updates for biopharma and med tech, including data readouts and publications: Bioversys, Can-Fite, Cerevasc, Citius,Clearmind, Kyowa Kirin, Relief, Tensive.

Biopharma and med-tech companies raising money in public or private financings, including: Aim Immunotech, Blackstone, Persevere, Sernova, Teva.

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Asieris, Atara,Dxcover, Hua, Johnson & Johnson, Meiji Seika, Northsea,Pathai, Pharmaessentia, Pierre Fabre , Priovant, Recovryai, Splisense.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Adial, Celltype, Cirna, Congruence, Corstasis, Curie.Bio, Esperion, Forendos, Hepion, Kdventures, Molteni, Ono, Organon, Secarna, Senhwa, Sinopia.

Clinical updates for biopharma and med tech, including data readouts and publications: Bioaffinity, Biocardia, Chiesi, Cour, Delcath, Ensysce, Quell, Snipr, Theravance.